Raras
Buscar doenças, sintomas, genes...
Osteólise rara
ORPHA:93449DOENÇA RARA

Tuberculose, também conhecida como "tuberculose pulmonar", "tísica" ou "tísica pulmonar", é uma doença infeciosa causada pela bactéria Mycobacterium tuberculosis (MTB). A tuberculose afeta geralmente os pulmões, embora possa também afetar outras partes do corpo. A maioria das infeções não manifesta sintomas, sendo nesses casos denominada tuberculose latente. Cerca de 10% das infeções latentes evoluem para tuberculose ativa. Se não for tratada, a tuberculose ativa causa a morte a metade das pessoas infectadas. Os sintomas clássicos da tuberculose ativa são tosse crónica com expulsão de sangue, escarro, febre, suores noturnos e perda de peso.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Doença rara caracterizada por perda óssea progressiva e generalizada, levando a osteoporose severa e deformidades esqueléticas. Pode apresentar aplasia/hipoplasia de clavículas, morfologia anormal dos dedos e cílios ausentes, associada a envelhecimento precoce e, em alguns casos, disfunção cardíaca.

Publicações científicas
6 artigos
Último publicado: 2015 Jul
Medicamentos
4 registrados
LONAFARNIB, PRAVASTATIN, ZOLEDRONIC ACID

Tem tratamento?

4 medicamentos registrados
Ver detalhes, fases e interações →
LONAFARNIBPRAVASTATINZOLEDRONIC ACIDZOLEDRONIC ACID ANHYDROUS
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
86 sintomas
😀
Face
35 sintomas
🧬
Pele e cabelo
30 sintomas
❤️
Coração
26 sintomas
🧠
Neurológico
24 sintomas
📏
Crescimento
18 sintomas

+ 174 sintomas em outras categorias

Características mais comuns

Osteoporose generalizada
Morfologia anormal da ponta do dedo
Aplasia mamária
Aparência de envelhecimento prematuro
Aplasia/Hipoplasia das clavículas
Anormalidade do sistema esquelético
478sintomas
Sem dados (478)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 478 características clínicas mais associadas, ordenadas por frequência.

Osteoporose generalizadaGeneralized osteoporosis
Morfologia anormal da ponta do dedoAbnormal fingertip morphology
Aplasia mamáriaBreast aplasia
Aparência de envelhecimento prematuroPrematurely aged appearance
Aplasia/Hipoplasia das clavículasAplasia/Hypoplasia of the clavicles

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa11desde 2015
Total histórico6PubMed
Últimos 10 anos1publicações
Pico20151 papers
Linha do tempo
20202015Hoje · 2026🧪 2009Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

11 genes identificados com associação a esta condição.

MAFBTranscription factor MafBDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Acts as a transcriptional activator or repressor (PubMed:27181683). Plays a pivotal role in regulating lineage-specific hematopoiesis by repressing ETS1-mediated transcription of erythroid-specific genes in myeloid cells. Required for monocytic, macrophage, osteoclast, podocyte and islet beta cell differentiation. Involved in renal tubule survival and F4/80 maturation. Activates the insulin and glucagon promoters. Together with PAX6, transactivates weakly the glucagon gene promoter through the G

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Activation of anterior HOX genes in hindbrain development during early embryogenesis
MECANISMO DE DOENÇA

Multicentric carpotarsal osteolysis syndrome

A rare skeletal disorder, usually presenting in early childhood with a clinical picture mimicking juvenile rheumatoid arthritis. Progressive destruction of the carpal and tarsal bone usually occurs and other bones may also be involved. Chronic renal failure is a frequent component of the syndrome. Intellectual disability and minor facial anomalies have been noted in some patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
181.0 TPM
Skin Sun Exposed Lower leg
133.1 TPM
Skin Not Sun Exposed Suprapubic
83.0 TPM
Tecido adiposo
63.3 TPM
Mama
50.0 TPM
OUTRAS DOENÇAS (4)
multicentric carpo-tarsal osteolysis with or without nephropathyDuane retraction syndrome 3 with or without deafnessDuane retraction syndromeDuane retraction syndrome with congenital deafness
HGNC:6408UniProt:Q9Y5Q3
BANF1Barrier-to-autointegration factorDisease-causing germline mutation(s) inDesconhecido
FUNÇÃO

Non-specific DNA-binding protein that plays key roles in mitotic nuclear reassembly, chromatin organization, DNA damage response, gene expression and intrinsic immunity against foreign DNA (PubMed:10908652, PubMed:11792822, PubMed:12163470, PubMed:18005698, PubMed:25991860, PubMed:28841419, PubMed:31796734, PubMed:32792394). Contains two non-specific double-stranded DNA (dsDNA)-binding sites which promote DNA cross-bridging (PubMed:9465049). Plays a key role in nuclear membrane reformation at th

LOCALIZAÇÃO

NucleusChromosomeNucleus envelopeCytoplasm

VIAS BIOLÓGICAS (4)
Initiation of Nuclear Envelope (NE) ReformationVpr-mediated nuclear import of PICsIntegration of provirusAPOBEC3G mediated resistance to HIV-1 infection
MECANISMO DE DOENÇA

Nestor-Guillermo progeria syndrome

An atypical progeroid syndrome characterized by normal development in the first years of life, later followed by the emergence of generalized lipoatrophy, severe osteoporosis, and marked osteolysis. The atrophic facial subcutaneous fat pad and the marked osteolysis of the maxilla and mandible result in a typical pseudosenile facial appearance with micrognathia, prominent subcutaneous venous patterning, a convex nasal ridge, and proptosis. Cognitive development is completely normal. Patients do not have cardiovascular dysfunction, atherosclerosis, or metabolic anomalies.

OUTRAS DOENÇAS (1)
Nestor-Guillermo progeria syndrome
HGNC:17397UniProt:O75531
ANTXR2Anthrax toxin receptor 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Necessary for cellular interactions with laminin and the extracellular matrix (Microbial infection) Receptor for the protective antigen (PA) of B.anthracis (PubMed:12700348, PubMed:15243628, PubMed:15326297). Binding of PA leads to heptamerization of the receptor-PA complex (PubMed:12700348, PubMed:15243628, PubMed:15326297). Upon binding of the PA of B.anthracis, the complex moves to glycosphingolipid-rich lipid rafts, where it is internalized via a clathrin-dependent pathway (PubMed:12551953,

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulum membraneSecreted

VIAS BIOLÓGICAS (1)
Uptake and function of anthrax toxins
MECANISMO DE DOENÇA

Hyaline fibromatosis syndrome

An autosomal recessive syndrome characterized by abnormal growth of hyalinized fibrous tissue usually affecting subcutaneous regions on the scalp, ears, neck, face, hands, and feet. The lesions appear as pearly papules or fleshy nodules. Additional features include gingival hypertrophy, progressive joint contractures resulting in severe limitation of mobility, osteopenia, and osteoporosis. Disease severity is variable. Some individuals manifest symptoms in infancy and have additional visceral or systemic involvement. Hyaline deposits in multiple organs, recurrent infections and intractable diarrhea often lead to early death. Surviving children may suffer from severely reduced mobility due to joint contractures. Other patients have later onset of a milder disorder affecting only the face and digits.

INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (3)
hyaline fibromatosis syndromeinfantile systemic hyalinosisjuvenile hyaline fibromatosis
HGNC:21732UniProt:P58335
NOTCH2Neurogenic locus notch homolog protein 2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Functions as a receptor for membrane-bound ligands Jagged-1 (JAG1), Jagged-2 (JAG2) and Delta-1 (DLL1) to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus (PubMed:21378985, PubMed:21378989). Affects the implementation of differentiation, proliferation and apoptotic programs (By similarity). Involved in bone remodeling and

LOCALIZAÇÃO

Cell membraneNucleusCytoplasm

VIAS BIOLÓGICAS (1)
Pre-NOTCH Processing in Golgi
MECANISMO DE DOENÇA

Alagille syndrome 2

A form of Alagille syndrome, an autosomal dominant multisystem disorder. It is clinically defined by hepatic bile duct paucity and cholestasis in association with cardiac, skeletal, and ophthalmologic manifestations. There are characteristic facial features and less frequent clinical involvement of the renal and vascular systems.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
76.5 TPM
Aorta
56.8 TPM
Artéria tibial
52.2 TPM
Skin Sun Exposed Lower leg
42.2 TPM
Skin Not Sun Exposed Suprapubic
40.2 TPM
OUTRAS DOENÇAS (2)
acroosteolysis dominant typeAlagille syndrome due to a NOTCH2 point mutation
HGNC:7882UniProt:Q04721
MMP14Matrix metalloproteinase-14Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Endopeptidase that degrades various components of the extracellular matrix such as collagen (PubMed:8015608). Essential for pericellular collagenolysis and modeling of skeletal and extraskeletal connective tissues during development (By similarity). Activates progelatinase A/MMP2, thereby acting as a positive regulator of cell growth and migration (PubMed:22065321, PubMed:8015608). Involved in the formation of the fibrovascular tissues in association with pro-MMP2 (PubMed:12714657, PubMed:220653

LOCALIZAÇÃO

Cell membraneMelanosomeCytoplasm

VIAS BIOLÓGICAS (1)
Activation of Matrix Metalloproteinases
MECANISMO DE DOENÇA

Winchester syndrome

A disease characterized by severe osteolysis in the hands and feet, generalized osteoporosis, bone thinning, and absence of subcutaneous nodules. Various additional features include coarse face, corneal opacities, gum hypertrophy, and EKG changes.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
620.2 TPM
Cervix Endocervix
354.6 TPM
Cervix Ectocervix
345.8 TPM
Útero
294.1 TPM
Tecido adiposo
262.0 TPM
OUTRAS DOENÇAS (2)
Winchester syndromemulticentric osteolysis-nodulosis-arthropathy spectrum
HGNC:7160UniProt:P50281
LMNAPrelamin-A/CDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Lamins are intermediate filament proteins that assemble into a filamentous meshwork, and which constitute the major components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane (PubMed:10080180, PubMed:10580070, PubMed:10587585, PubMed:10814726, PubMed:11799477, PubMed:12075506, PubMed:12927431, PubMed:15317753, PubMed:18551513, PubMed:18611980, PubMed:2188730, PubMed:22431096, PubMed:2344612, PubMed:23666920, PubMed:24741066, PubMed:31434876, PubMed:

LOCALIZAÇÃO

Nucleus laminaNucleus envelopeNucleus, nucleoplasmNucleus matrixNucleus speckle

VIAS BIOLÓGICAS (1)
Initiation of Nuclear Envelope (NE) Reformation
MECANISMO DE DOENÇA

Emery-Dreifuss muscular dystrophy 2, autosomal dominant

A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
392.7 TPM
Aorta
300.6 TPM
Skin Not Sun Exposed Suprapubic
297.7 TPM
Skin Sun Exposed Lower leg
272.6 TPM
Útero
255.8 TPM
OUTRAS DOENÇAS (23)
restrictive dermopathy 2familial partial lipodystrophy, Dunnigan typedilated cardiomyopathy-hypergonadotropic hypogonadism syndromemandibuloacral dysplasia with type A lipodystrophy
HGNC:6636UniProt:P02545
ZMPSTE24CAAX prenyl protease 1 homologDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Transmembrane metalloprotease whose catalytic activity is critical for processing lamin A/LMNA on the inner nuclear membrane and clearing clogged translocons on the endoplasmic reticulum (PubMed:33293369, PubMed:33315887). Proteolytically removes the C-terminal three residues of farnesylated proteins (PubMed:33293369, PubMed:33315887). Also plays an antiviral role independently of its protease activity by restricting enveloped RNA and DNA viruses, including influenza A, Zika, Ebola, Sindbis, ves

LOCALIZAÇÃO

Endoplasmic reticulum membraneNucleus inner membraneEarly endosome membraneLate endosome membrane

MECANISMO DE DOENÇA

Mandibuloacral dysplasia with type B lipodystrophy

A form of mandibuloacral dysplasia, a rare progeroid disorder with clinical and genetic heterogeneity, characterized by growth retardation, craniofacial dysmorphic features due to distal bone resorption, musculoskeletal and skin abnormalities associated with lipodystrophy. MADB is a disease characterized by mandibular and clavicular hypoplasia, acroosteolysis, delayed closure of the cranial suture, joint contractures, and generalized lipodystrophy with loss of subcutaneous fat from the extremities, face, neck and trunk.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
70.8 TPM
Fibroblastos
63.2 TPM
Útero
58.5 TPM
Fallopian Tube
49.5 TPM
Artéria coronária
43.6 TPM
OUTRAS DOENÇAS (4)
mandibuloacral dysplasia with type B lipodystrophyrestrictive dermopathy 1restrictive dermopathyHutchinson-Gilford progeria syndrome
HGNC:12877UniProt:O75844
TYROBPTYRO protein tyrosine kinase-binding proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Adapter protein which non-covalently associates with activating receptors found on the surface of a variety of immune cells to mediate signaling and cell activation following ligand binding by the receptors (PubMed:10604985, PubMed:9490415, PubMed:9655483). TYROBP is tyrosine-phosphorylated in the ITAM domain following ligand binding by the associated receptors which leads to activation of additional tyrosine kinases and subsequent cell activation (PubMed:9490415). Also has an inhibitory role in

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (6)
DAP12 signalingDAP12 interactionsOther semaphorin interactionsSignal regulatory protein family interactionsNeutrophil degranulation
MECANISMO DE DOENÇA

Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1

A recessively inherited disease characterized by presenile dementia along with large-scale destruction of cancellous bones. Initial symptoms, starting in the twenties, are pain and swelling resulting from cysts in the wrists and ankles. Extremity bone fractures could occur with minor trauma. At around 30 years of age, patients gradually develop neuropsychiatric symptoms, including epileptic seizures, agnosia, apraxia, speech disorder, memory disturbance, euphoria, and loss of social inhibitions. The disorder usually leads to death in the fifth decade of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
1786.3 TPM
Baço
563.6 TPM
Pulmão
404.2 TPM
Adipose Visceral Omentum
142.5 TPM
Tecido adiposo
131.6 TPM
OUTRAS DOENÇAS (2)
polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1polycystic lipomembranous osteodysplasia with sclerosing leukoencephaly
HGNC:12449UniProt:O43914
TREM2Triggering receptor expressed on myeloid cells 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Forms a receptor signaling complex with TYROBP which mediates signaling and cell activation following ligand binding (PubMed:10799849). Acts as a receptor for amyloid-beta protein 42, a cleavage product of the amyloid-beta precursor protein APP, and mediates its uptake and degradation by microglia (PubMed:27477018, PubMed:29518356). Binding to amyloid-beta 42 mediates microglial activation, proliferation, migration, apoptosis and expression of pro-inflammatory cytokines, such as IL6R and CCL3, a

LOCALIZAÇÃO

Cell membraneSecreted

VIAS BIOLÓGICAS (4)
DAP12 signalingDAP12 interactionsOther semaphorin interactionsImmunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
MECANISMO DE DOENÇA

Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2

An autosomal recessive disease characterized by presenile frontal dementia with leukoencephalopathy and basal ganglia calcification. In most cases the disorder first manifests in early adulthood as pain and swelling in ankles and feet, followed by bone fractures. Neurologic symptoms manifest in the fourth decade of life as a frontal lobe syndrome with loss of judgment, euphoria, and disinhibition. Progressive decline in other cognitive domains begins to develop at about the same time. The disorder culminates in a profound dementia and death by age 50 years.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
47.7 TPM
Substância negra
20.1 TPM
Pulmão
17.4 TPM
Nervo tibial
14.5 TPM
Hipotálamo
10.7 TPM
OUTRAS DOENÇAS (8)
polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2amyotrophic lateral sclerosisprogressive non-fluent aphasiabehavioral variant of frontotemporal dementia
HGNC:17761UniProt:Q9NZC2
MMP272 kDa type IV collagenaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Ubiquitinous metalloproteinase that is involved in diverse functions such as remodeling of the vasculature, angiogenesis, tissue repair, tumor invasion, inflammation, and atherosclerotic plaque rupture. As well as degrading extracellular matrix proteins, can also act on several nonmatrix proteins such as big endothelial 1 and beta-type CGRP promoting vasoconstriction. Also cleaves KISS at a Gly-|-Leu bond. Appears to have a role in myocardial cell death pathways. Contributes to myocardial oxidat

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrixMembraneNucleusCytoplasmMitochondrion

VIAS BIOLÓGICAS (1)
Activation of Matrix Metalloproteinases
MECANISMO DE DOENÇA

Multicentric osteolysis, nodulosis, and arthropathy

An autosomal recessive syndrome characterized by severe multicentric osteolysis with predominant involvement of the hands and feet. Additional features include coarse face, corneal opacities, patches of thickened, hyperpigmented skin, hypertrichosis and gum hypertrophy.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
908.4 TPM
Cervix Ectocervix
669.0 TPM
Cervix Endocervix
635.7 TPM
Tecido adiposo
545.0 TPM
Skin Sun Exposed Lower leg
434.0 TPM
OUTRAS DOENÇAS (2)
multicentric osteolysis, nodulosis, and arthropathymulticentric osteolysis-nodulosis-arthropathy spectrum
HGNC:7166UniProt:P08253
TNFRSF11ATumor necrosis factor receptor superfamily member 11ADisease-causing germline mutation(s) inTolerante
FUNÇÃO

Receptor for TNFSF11/RANKL/TRANCE/OPGL; essential for RANKL-mediated osteoclastogenesis (PubMed:9878548). Its interaction with EEIG1 promotes osteoclastogenesis via facilitating the transcription of NFATC1 and activation of PLCG2 (By similarity). Involved in the regulation of interactions between T-cells and dendritic cells (By similarity)

LOCALIZAÇÃO

Cell membraneMembrane raft

VIAS BIOLÓGICAS (2)
TNFR2 non-canonical NF-kB pathwayTNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
MECANISMO DE DOENÇA

Familial expansile osteolysis

Rare autosomal dominant bone disorder characterized by focal areas of increased bone remodeling. The osteolytic lesions develop usually in the long bones during early adulthood. FEO is often associated with early-onset deafness and loss of dentition.

EXPRESSÃO TECIDUAL(Tecido-específico)
Glândula salivar
10.6 TPM
Pituitária
9.9 TPM
Cólon transverso
8.4 TPM
Intestino delgado
7.9 TPM
Skin Sun Exposed Lower leg
2.8 TPM
OUTRAS DOENÇAS (6)
familial expansile osteolysisautosomal recessive osteopetrosis 7adult-onset myasthenia gravisdysosteosclerosis
HGNC:11908UniProt:Q9Y6Q6

Medicamentos e terapias

LONAFARNIBPhase 4

Mecanismo: Protein farnesyltransferase inhibitor

PRAVASTATINPhase 2

Mecanismo: HMG-CoA reductase inhibitor

ZOLEDRONIC ACIDPhase 2

Mecanismo: Farnesyl diphosphate synthase inhibitor

ZOLEDRONIC ACID ANHYDROUSPhase 2

Mecanismo: Farnesyl diphosphate synthase inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

119 variantes patogênicas registradas no ClinVar.

🧬 MAFB: GRCh37/hg19 20q11.21-13.12(chr20:31010829-44560369)x1 ()
🧬 MAFB: NM_005461.5(MAFB):c.509C>A (p.Ser170Ter) ()
🧬 MAFB: NM_005461.5(MAFB):c.284T>A (p.Met95Lys) ()
🧬 MAFB: NM_005461.5(MAFB):c.618C>A (p.Ser206Arg) ()
🧬 MAFB: NM_005461.5(MAFB):c.136T>C (p.Cys46Arg) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

41 vias biológicas associadas aos genes desta condição.

Activation of anterior HOX genes in hindbrain development during early embryogenesis Integration of provirus 2-LTR circle formation Integration of viral DNA into host genomic DNA Autointegration results in viral DNA circles APOBEC3G mediated resistance to HIV-1 infection Vpr-mediated nuclear import of PICs Nuclear Envelope Breakdown Initiation of Nuclear Envelope (NE) Reformation Uptake and function of anthrax toxins Pre-NOTCH Processing in the Endoplasmic Reticulum Pre-NOTCH Transcription and Translation Pre-NOTCH Processing in Golgi NOTCH2 intracellular domain regulates transcription NOTCH2 Activation and Transmission of Signal to the Nucleus Notch-HLH transcription pathway Defective LFNG causes SCDO3 NOTCH4 Intracellular Domain Regulates Transcription Collagen degradation Degradation of the extracellular matrix Activation of Matrix Metalloproteinases TGFBR3 PTM regulation High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells Meiotic synapsis Breakdown of the nuclear lamina XBP1(S) activates chaperone genes Depolymerization of the Nuclear Lamina Signaling by BRAF and RAF1 fusions Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell DAP12 interactions DAP12 signaling Signal regulatory protein family interactions Other semaphorin interactions Neutrophil degranulation Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) EPH-ephrin mediated repulsion of cells Interleukin-4 and Interleukin-13 signaling Extra-nuclear estrogen signaling TNFR2 non-canonical NF-kB pathway TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado1
2Fase 23
Medicamentos catalogadosEnsaios clínicos· 4 medicamentos · 0 ensaios
✓ Aprovados — podem ser usados hoje
LONAFARNIB
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Osteólise rara

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
1 papers (10 anos)

Publicações recentes

Ver todas no PubMed

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Osteólise rara.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Osteólise rara

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Primary osteolysis syndromes: beware of difficult airway.
    Paediatric anaesthesia· 2015· PMID 25736220mais citado
  2. Gorham disease of the craniocervical junction: X-ray, computed tomography, and magnetic resonance imaging findings.
    Spine J· 2013· PMID 23462515recente
  3. Surfer's toe: trauma-induced idiopathic acro-osteolysis in the toes of a 46-year-old surfer: a case report.
    J Am Podiatr Med Assoc· 2012· PMID 22461275recente
  4. Osseous metastases in breast cancer: radiographic monitoring of therapeutic response.
    Anticancer Res· 2002· PMID 12168938recente
  5. [Post-traumatic osteolysis of the distal extremity of the clavicle. Anatomopathological study of 2 cases].
    Rev Rhum Mal Osteoartic· 1992· PMID 1609239recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:93449(Orphanet)
  2. MONDO:0019707(MONDO)
  3. GARD:19204(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q55788819(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Osteólise rara
Compêndio · Raras BR

Osteólise rara

ORPHA:93449 · MONDO:0019707
Medicamentos
4 registrados
MedGen
UMLS
C5559806
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades